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Background. The Netherlands does not have a national haemoglobinopathy (HbP)-carrier screen-
ing programme aimed at facilitating informed reproductive choice. HbP-carrier testing for those at 
risk is at best offered on the basis of anaemia. Registration of ethnicity has proved controversial 
and may complicate the introduction of a screening programme if based on ethnicity. However, 
other factors may also play a role.
Objective. To explore perceived barriers and attitudes among GPs and midwives regarding the 
registration of ethnicity and ethnicity-based HbP-carrier screening.
Methods. Six focus groups in Dutch primary care, with a total of 37 GPs (n = 9) and midwives 
(n = 28) were conducted, transcribed and content analysed using Atlas-ti.
Results. Both GPs and midwives struggled with correctly identifying ethnicities at risk for HbP. 
Ethical concerns regarding privacy seemed to originate from World War II experiences, when eth-
nic and religious registration facilitated deportation of Jewish citizens, coupled with the political 
climate at the time focus groups were held. Some respondents thought the ethnicity question 
might undermine the relationship with their clients. Software programmes prevented GPs from 
registering ethnicity of patients at risk. Financial implications for patients were also a concern. 
Despite this, respondents seemed positive about screening and were familiar with identifying 
ethnicity and used this for individual patient care.
Conclusions. Although health professionals are generally positive about screening, ethical, finan-
cial and practical issues surrounding ethnicity-based HbP-carrier screening need to be clarified 
before introducing such a programme. Primary care professionals can be targeted through profes-
sional organizations but they need national policy support.
Keywords. Barriers, carrier screening, ethnicity, haemoglobinopathies, primary care.
Introduction
Haemoglobinopathies (HbPs), such as sickle cell 
disease and thalassaemia, are autosomal recessive 
disorders with severe anaemia, variable but lifelong 
morbidity and a shortened lifespan due to multi-organ 
ischaemic damage.1,2 HbPs occur more frequently 
in areas such as Africa, the Mediterranean area, the 
Middle East and South-East Asia. Due to migration 
and population admixture, HbPs are now also common 
in other countries. Carrier prevalence amongst the 
general population in Northern and Western Europe 
varies between 0.29% in Finland and 2.45% in France.3 
However, when ethnicity is taken into account, carrier 
prevalence may vary up to 40%,4 making ethnicity an 
important determinant of risk. Carrier couples have a 
one-in-four chance in each pregnancy of giving birth 
to an affected child. Carrier screening would allow 
the identification of these couples and give them an 
opportunity to make informed reproductive decisions, 
preferably before conception. The Netherlands, as 
many other countries in Europe, does not have a 
national HbP-carrier screening programme. Although 
national guidelines advise HbP-carrier testing in cases 
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of (unresolved) anaemia or a positive family history,5,6 
health professionals such as GPs and midwives rarely 
carry this out. Being part of primary care, midwives 
and GPs are in a good position to provide easy access 
to preconception care. The vast majority of pregnant 
women (78%) start their maternity care in a primary 
care setting.7 Preconception or early antenatal HbP-
carrier testing would facilitate reproductive choice for 
(prospective) parents. Although preconception care 
has been implemented by midwives and is also gaining 
attention from GPs in the Netherlands, it is hindered 
by a lack of financial support.5,8 Preconception care is 
therefore only available to those with sufficient financial 
means or an extensive insurance policy.
Several studies have shown that both health pro-
fessionals and groups at risk support HbP-carrier 
screening.9–12 One of the explanations for the rarity 
of testing may be our earlier finding in a question-
naire survey11 that HbP testing is influenced by peer 
behaviour. As official policy is lacking and colleagues 
rarely offer testing,10 peer influence to test for car-
rier state among those at risk is presumably low. 
As (targeted) screening has not been implemented 
and recessive disorders such as HbPs are often not 
apparent in families, carriers of HbPs remain largely 
unidentified.
There are several arguments for implementation 
of targeted screening based on ethnicity, including 
economic ones.13 HbP-carrier status can easily and 
cheaply be determined by a high-performance liquid 
chromatography (HPLC) test. But ‘before’ testing 
is offered, couples preferably need to be accurately 
informed about their a priori risk so that health care 
professionals can facilitate the choice for testing. Since 
HbP (carrier) prevalence differs across ethnic groups, 
the identification of ethnicity might still be necessary. 
Besides, identification of ethnicity might be needed to 
further investigate mutations. In England, where ante-
natal HbP-carrier screening was introduced in 2004, 
self-identified ethnicity based on a family origin ques-
tionnaire is determined to assess HbP risk in both low-
prevalence areas where targeted screening is practised 
and in high-prevalence areas where universal screen-
ing is the norm.14
Research by Dyson et  al. showed that health care 
workers struggle with the ethnicity question as a 
screening tool and worry about the sensitivities related 
to ethnicity.15 In the Netherlands, ethnic registration 
has proved to be a controversial issue rooted in the his-
tory of World War II (WWII) and it was linked to the 
nationalistic political climate at the time of our study 
(2010).16 These issues came up as barriers for the intro-
duction of HbP-carrier screening.11,17 In order to offer 
equitable health services to all groups in society, health 
professionals need to be aware of ethnicity-related 
health needs without the fear of raising issues of dis-
crimination or stigmatization.
Objective
This study’s objective was to gain more insight into the 
present attitudes towards the documentation of ethnic-
ity in clinical records by GPs and midwives related to 
everyday practice, in particular to identify risk groups 
for preconceptional or antenatal HbP-carrier testing 
and to explore perceived barriers if ethnicity-based 
HbP-carrier screening is implemented in the future.
Methods
Design and setting
This qualitative study is part of a broader study exam-
ining ethnicity-based HbP screening.11,17 As both ‘eth-
nicity’ and ‘ancestry’ are shown to be equally complex 
terms and ethnicity is supported by the literature as a 
proxy for ancestral or ethnic origin,18 this term has been 
chosen to be used in the study. Moreover, this term is 
most common in areas of health care such as midwifery 
and obstetrics.7
A focus group study was designed as this method 
stimulates debate and explores ideas about the topics 
introduced. Moreover, we aimed to deepen the issues 
of interest as identified by a previous questionnaire 
study.11
Focus groups were homogeneous with regard to 
health profession in order to generate a sufficient feel-
ing of security among participants. The semi-structured 
topic guide was based on the literature and the results of 
the aforementioned questionnaire study. The question-
naire study showed that almost half of respondents are 
in favour of HbP-carrier testing on the basis of ethnic-
ity and are of the opinion that a national screening pol-
icy should be implemented. Respondents reported that 
they very rarely carry out HbP-carrier testing at present. 
Topics in the focus group discussion protocol included 
participants’ experience with HbP-carrier testing (also 
related to neonatal screening for sickle cell disease, 
which was implemented in the Netherlands in 2007,19 
opinions on a possible HbP-screening programme, atti-
tudes regarding ethnic registration in clinical records 
also related to HbP screening, perceived barriers and 
possible solutions for the potential implementation of a 
HbP-carrier screening programme. Prior to the start of 
the focus group, participants received a brief HbP fact 
sheet by post based on existing professional guidelines 
with which participants should already be familiar,6,20 
giving disease background and information on groups 
at risk. Participants were asked to complete basic back-
ground questions and provide written consent.
The focus group discussions took place at two 
universities and a midwifery academy; they lasted ~90 
minutes and were facilitated by one of two moderators 
(LvT, a health scientist, or CvE, a sociologist). The 
primary researcher (SJ, midwife) was only involved in 
the GP group as note taker to prevent influencing the 
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discussion of her colleagues. Another assistant took notes 
in the midwives group. Midwives received professional 
register credits in return for participation, whereas GPs 
did not, as this was not facilitated by their professional 
organization. All participants received a €10 gift voucher 
but were not informed of this prior to the discussion.
Participant recruitment and data collection
Primary care practitioners were asked to participate by 
means of a letter included in the postal questionnaire 
(sent to all 1800 primary care midwives and a random 
sample of 2000 GPs) on ethnicity-based HbP screen-
ing.11 To this letter, 29 GPs and 191 midwives responded. 
We selected a regionally based purposeful sample from 
among the responders, on the assumption that rural 
health professionals would have less experience with 
groups at high risk for HbP. Our sample included six 
focus groups of about six midwives or GPs each, with a 
total of 37 individuals aged 23–65 years. In the autumn 
of 2010, four focus groups were held with midwives 
(n  =  28) and two with GPs (n  =  9), after which satu-
ration was achieved concerning the midwives. Digital 
audio recordings of the discussions were collected and 
anonymously transcribed.
 Several attempts were made to recruit more GPs but 
these proved unsuccessful. Although most midwives 
were women, the mostly male GPs had more working 
years’ experience compared with the midwives. Even 
so, midwives were more familiar with preconception 
care and looked after a larger percentage of the popu-
lation at risk for HbPs (Table 1).
Analysis
The transcripts were checked once to ensure accuracy 
and to gain familiarity with the data and these were 
subsequently content analysed (SJ). Transcripts were 
searched for common themes but also for deviant 
cases and subsequently indexed as codes. The coding 
frame was developed by the primary researcher (SJ), 
in consultation with two other researchers (LH, health 
scientist, and CvE). SJ coded the transcripts and CvE 
and LH each verified one-third of the transcripts as 
an inter-rater check. The codes were grouped together 
into key themes. Codes and emerging themes were 
compared for coding reliability through a process of 
discussion and deliberation of themes and connections 
(SJ, LH, and CvE). ATLAS.ti software package (version 
5.2.0) was used to support the analysis of the transcripts.
Results
General attitudes towards HbP-carrier screening were 
mixed. Although practitioners thought it to be good 
practice and that it would fulfil a health need, they also 
questioned the cost-effectiveness and necessity because 
of perceived low prevalence. Data analysis identified 
four themes related to ethnicity-based carrier screening: 
defining ethnicity; ethical dilemmas and sensitivities; 
ethnic awareness and good practice; and practicalities. 
All these themes are discussed and illustrated here by 
representative quotations from the discussions, trans-
lated from Dutch. The participant’s group and their 
occupation type (GP or midwife) are given in brackets.
Defining ethnicity: who is at higher risk?
The issue that generated most discussion in all focus 
groups was the concern of being able to correctly 
identify those individuals at higher risk for HbPs. 
Participants wondered how ethnicities can be defined 
and thus how they could correctly identify those at risk: 
by appearance, by name, or by country of birth?
So they might look Hindustani [Surinam people 
of Indian origin] but there might be some black or 
something, (.  . .) but how strong . . . wouldn’t you 
need to test them?
Midwife (Group 6)
But no, I  believe all those Mediterranean people 
are Caucasian too and that is clearly a different 
ethnicity. Because I [this GP is of Dutch ethnic ori-
gin] don’t have a higher risk of HbP and they do. So 
yes, the way you define ethnicity puts you immedi-
ately in a morass of difficult considerations.
GP (Group 2)
Participants wondered how far back they would have to 
look into a person’s ethnic origin to determine their risk 
of being a HbP carrier.
How strong is HbP in the inheritance? (. . .) How 
much white; lets say how much percent of some-
thing else do you need to take away the effect? This 
is what I don’t know (. . .). Percentages will drop the 
more mixing there is. But it’s still only a chance and 
you have a chance of one in two (sic) that it will 
be passed on to you and that will always remain if 
your parents have it.
Midwife (Group 6)
Table 1 Characteristics of participants in the focus groups
Characteristics Midwives (n = 28) GPs (n = 9)
Mean age, years (SD) 35.4 (11.3) 51.4 (11.2)
Female gender, n (%) 27 (96) 2 (22)
Dutch, n (%) 27 (96) 9 (100)
Mean practice experience, years 
(SD) 
10.4 (9.2) 22.0 (11.7)
Estimated population at risk in 
practice, %
27 20
Urban practice, n (%) 18 (64) 4 (44)
Gives preconception care, n (%) 14 (50) 4 (44)
GP, general practitioner.
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Both GPs and midwives also struggled with mixed 
backgrounds of their patients and clients, which made 
them feel unsure how to handle this in daily practice 
and uncertain whom to offer screening:
But what do you do with someone who has an 
Indonesian mother and an Italian father and she 
is married to a Dutch man, you know, these people 
can also have carrier (. . .) The fact that people are 
so intertwined, so often, well that is, we see a lot 
of people with mixed backgrounds and what is the 
limit [cut-off point], with which background?
Midwife (Group 3)
Participants seemed aware that determining ethnic ori-
gin with regard to HbP-carrier screening entails more 
than identifying someone’s place or country of birth.
I mean, they are from Moroccan descent that’s 
what it’s all about of course, the ethnicity on the 
basis of genetics and not let’s say . . . the ancestors, 
yes, so the country of birth of their parents counts, 
but let’s say as a person I don’t really have someone 
in front of me with a lot of Moroccan influences, 
her Dutch influences are much bigger.
Midwife (Group 5)
Ethical dilemmas and sensitivities
Both midwives and GPs had several, sometimes quite 
strong, ethical opinions concerning ethnic documenta-
tion in clinical records. Specifically, GPs felt burdened 
by ethical objections that stem from Dutch experiences 
during WWII, when ethnic and religious registration 
facilitated mass deportation of Jewish citizens.
But if you think a bit further, at the time of Hitler and 
the Jewish people et cetera; they carried out all sorts 
of scary experiments with different ethnic populations, 
that was on the basis of you know . . . Jews and Gypsies 
and I don’t know who . . . And if we would register all 
of that and it would be registered somewhere that you 
are Caucasian; Muslim; African or whatever else: Go 
ahead think about it, in times of, people, well in the 
craziness of war strange things can happen . . .
Midwife (Group 5)
One GP said that he would not object to the docu-
mentation of ethnicity in clinical records and that it 
could potentially be useful, but despite this, he still 
felt distrust and maintains his recordkeeping to a 
minimum:
I register as little as possible. And well, I wouldn’t 
object [to ethnic registration] if it was possible to 
do this correctly and in a way that’s reproducible. 
I know we have a huge trauma in the Netherlands 
caused by World War II when Jewish people were 
registered with the council and as Dutch citizens we 
diligently helped the Germans to deport them and 
we pretend to be the best country in the world. (. . .)
GP (Group 1)
Participants coupled this with the political climate 
(right wing and nationalist) at the time the focus groups 
were conducted and worried about the misuse of data 
that could threaten patient confidentiality. GPs espe-
cially felt very protective of their patients’ privacy and 
had little confidence in digital record keeping:
I have no trust whatsoever in that it [electronic 
patient record] won’t be used for anything but 
patient purposes. The safety and the trustworthiness 
of this still have to be verified and demonstrated in 
my opinion. I believe records can easily be hacked 
at the moment. Besides, I don’t know what govern-
mental authorities will do with this in the long run. 
At the moment we have a government which says 
they will only do the right thing but I am sorry the 
[Nationalist right wing political party] has a very 
large following and I am not sure what will happen 
in the future.
GP (Group 2)
The political climate, in which tolerance regarding eth-
nic and cultural differences is reduced, may also be at 
the root of midwives’ concerns. Participants seemed 
keen not to be seen as supportive of this and, therefore, 
felt uncomfortable asking the ethnicity question. Some 
seemed to think that clients might interpret this as a sign 
of being less welcoming to them compared to a client of 
Dutch descent and worried that confusion over ethnic-
ity, descent and nationality might possibly cause tension:
Are we just going to ask: ‘Hey where are you from? 
Where are your parents from?’. Because really they 
are just Dutch, but that’s what I find difficult; that 
I’m emphasizing that they are not Dutch originally. 
Although my impression is that they don’t seem to 
mind themselves. It’s more that it makes me feel 
uncomfortable.
Midwife (Group 5)
In contrast, one midwife said she did not mind at all 
asking her clients about their ethnicity to determine 
their risk; she felt the ethnicity question was a positive 
one, which helped her to get to know her clients:
People are proud of where they come from, so 
I mean, that’s something; why should it [documen-
tation of ethnicity] be an issue? And what is nice, 
well that is my opinion anyway, clients who come 
from elsewhere, they always like to, I  mean they 
enjoy talking about their special things, their cul-
ture and traditions. It is always interesting.
Midwife (Group 4)
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Midwifery participants voiced other privacy-related 
concerns related to the nature of genetic disorders in 
relation to paternity:
Well, I  think it can be really tricky, it’s the same 
with a rhesus negative status when a woman is con-
vinced that her partner is also rhesus negative and 
that she doesn’t want the anti-D (. . .) Some things 
might come out just like with this [HbP testing] he 
can or cannot be the father.
Midwife (Group 6)
It appears that worries such as these stem from the 
fact that midwives have the impression that women 
or couples may not be able to see the potential impact 
of accepting screening. Finding an appropriate way of 
informing women in pregnancy may thus be compli-
cated in many ways.
Ethnic awareness and good practice
Despite the sensitivities voiced by participants, they 
appeared to be familiar with identifying ethnicity for 
(other) health purposes and seemed to believe that it 
is good practice to be aware of different health needs 
among certain ethnic groups. They use their knowledge 
and earlier experiences to choose the appropriate care 
for their patients or clients; for example, diabetes risk 
in Surinamese people of Indian descent. This awareness 
also resulted in offering certain patients or clients a test 
for HbP-carrier status:
We don’t carry out standard [HbP carrier] screening. 
But we do test people with a low Hb or those who were 
very anaemic in a previous pregnancy and actually 
also those people with a Mediterranean background; 
we test them for sickle cell and thalassaemia when we 
send them for the usual Hb and Mean Corpuscular 
Volume (MCV) tests as our experience tells us that 
they are very often positive [for HbP carrier status].
Midwife (Group 5)
But again, one participant pointed out the fact that in 
her practice, they felt insecure about defining groups 
at higher risk of a positive HbP-carrier status and as a 
result, policy was inconsistent:
Part of our practice area is very white and another 
part has a lot of immigrants; probably 20–25% of 
our population. We screen black people for sickle 
cell but this is quite arbitrary because some people 
who are mixed [of mixed descent] are sometimes 
not screened, so our policy is not very consistent.
Midwife (Group 5)
Attention given to ethnic differences in clinical guide-
lines varies.21 In this case, some participants felt sup-
ported by ethnicity-specific recommendations in their 
guidelines, underlining the importance of professional 
and national clinical guidance:
I think on the basis of anaemia, of course we cur-
rently have a beautiful guideline for this purpose 
which is really easy to use; you just follow it and 
arrive at the point where you think it has to be a 
haemoglobinopathy.
GP (Group 1)
Practicalities in relation to (ethnicity-based) HbP-
carrier screening
Two practical barriers emerged during the focus 
group discussions: registration difficulties and finan-
cial issues. Despite the presented dilemmas, midwives 
reported that they have been registering ethnicity in the 
Netherlands Perinatal Register (PRN) since the 1970s, 
which contains national perinatal data for research 
purposes and care improvement. Software systems are 
improving the registration methods:
We register by means of our LVR [national peri-
natal register] but this is only a very general if 
not limited registration. Mediterranean, other 
European, the groups are very ‘broad’. We have 
now started with [new software program for mid-
wives] and with this program you can fill in country 
of birth, therefore you have the country of birth for 
everyone.
Midwife (Group 3)
The practical side of implementing ethnic documenta-
tion appeared to be no problem for the midwifery pro-
fession. However, this is not the case for GPs because 
the available GP software does not provide a simple 
way of doing this:
Yes, there is loads of space [in the software pro-
gram] but you have to be able to locate it [the 
information on ethnicity]. Like, it’s not a separate 
field [in the program] for which you can search, 
which you can select. (. . .) I think a computer nerd 
would be able to do it but not GPs in general. It has 
to be easy otherwise you won’t do it.
GP (Group 1)
Although midwifery and GP care is exempt from finan-
cial charges to patients or clients in the Dutch health 
care system, they are sometimes charged for extra (lab-
oratory) services, depending on how insurance compa-
nies apply the rules. Those midwives who already tested 
for HbP-carrier status expressed concern about the 
financial implications for their clients. Unclear financial 
regulations are apparently making them feel awkward 
about offering such tests:
That depends whether or not the insurance will 
pay. (. . .) And if people, I mean I don’t know how 
much a test like that costs, but if people receive a 
huge bill which they have to pay themselves . . . 
Midwife (Group 4)
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It appeared that midwives easily feel guilty about finan-
cially burdening their clients through the care they have 
proposed. Not being able to give clear explanations 
about financial implications may also result in com-
plaints from clients.
Discussion
This study took a qualitative thematic approach to pro-
vide a deeper understanding of the attitudes and it elu-
cidates the perceived barriers of midwives and GPs with 
regard to ethnicity-related HbP-carrier screening. Four 
themes were identified, which showed that participants 
use ethnicity in daily practice for a tailored approach 
towards their patient’s or client’s health but find it dif-
ficult to adequately identify ethnicity whereby uneasy 
feelings are experienced when broaching the subject. 
Respondents voiced strong concerns over privacy issues 
of their patients and clients. GPs do not have the possi-
bility to record ethnicity in their software programmes. 
Some respondents worried about the financial implica-
tions for their clients.
GPs were of an older generation compared with the 
midwives (none of them was old enough to remember 
WWII) and had more experience than the midwives, 
although few of them give preconception care. This 
limits the possibility of comparison between these two 
groups. The number of GP participants in our study was 
small. Lack of educational credits was not helpful and 
may have introduced some bias in recruitment. This 
meant that for the GPs, the intended purposeful sample 
became a convenience sample. Other studies have 
encountered similar problems in terms of response and 
have indicated that a high workload prevented GPs 
from participating in research.11,22,23 Minimal interest 
and the GPs’ popularity as research objects may also 
have influenced the lack of enthusiasm in participation. 
One GP in this study mentioned that the subject was 
low on her priority list considering the magnitude of 
(social) problems she encountered in her practice. It 
should further be emphasized that qualitative data are 
not intended to be generalized. Moreover, it is likely 
that participants in most qualitative studies tend to be 
those who have a greater-than-average interest in a 
subject and may therefore introduce some bias in the 
results.
The discussion on defining ethnicity was one of the 
most dominant ones in our study. Information on eth-
nicity can be used to determine risks for certain disor-
ders, such as HbPs, cystic fibrosis (CF), diabetes mellitus 
etc., which occur more often in certain ethnic groups. 
However, the use of ethnicity is problematic in both 
social and political terms.17,24 It is interesting to note 
that none of the participants actually thought of asking 
patients/clients themselves but mostly interpreted eth-
nicity from outward characteristics such as appearance 
and/or surname. Although self-defined ethnicity is 
favoured by some,25,26 defining ethnicity is still the sub-
ject of ongoing debate.18,27,28 A generally accepted way 
of determining ethnic groups is by country of birth 
and (grand-)parents’ country of birth, but this method 
misses third and fourth generations.28 Our study results 
correlate with the complexity of determining ethnic-
ity as demonstrated by others who have shown that a 
substantial proportion of ethnic groups give complex 
answers about their ethnic background (and which do 
not necessarily fit predetermined categories).24,27,29
As opposed to Dyson’s results,29 which showed no 
consistency in how the ethnicity question was inter-
preted (i.e. meaning place of birth, place of upbringing, 
family, ancestors or ethnic identity), the participants in 
this study seemed to have at least some awareness of 
the importance of ethnic origin with regard to HbP-
carrier screening. Whether this was due to the supplied 
fact sheet or otherwise is unclear nor is it clear whether 
this awareness is also apparent in clinical practice. Our 
study does support Dyson’s finding that midwives feel 
uncomfortable asking the ethnicity question. One way 
to reduce such feelings may be by offering combined 
screening for disorders, such as HbPs and CF, with dif-
ferent prevalences in different ethnic groups. Carrier 
screening for these disorders could be offered using a 
tool specifically designed for such purpose.12
GPs and midwives in this study are familiar with 
the use of ethnicity in daily practice for the purpose of 
tailored health care and are prepared to screen their 
patients for HbP-carrier status in the future. However, 
this also seems to create uncomfortable feelings that 
require further investigation. Although several instru-
ments are available for determining ethnic HbP risk,12,30 
it is not known what women and their partners think 
about ethnicity-related health care. No feelings of stig-
matization were found in case of the combined screen-
ing offer for HbP and CF mentioned above.
A previous study revealed ethnic registration to 
be a controversial barrier in the past, preventing the 
introduction of a HbP-carrier programme, which was 
rooted in the history of WWII and linked to the nation-
alistic political climate at the time the study was con-
ducted.11,17 This study shows that these issues continue 
to be important.
Of course, factors such as prevalence and burden of 
disease are determined first to assess the appropriate-
ness of screening. However, prevalence and burden of 
disease vary per ethnic group; therefore, for some ethnic 
groups, screening is more appropriate than for others.
Considering the complexity of determining ethnicity, 
universal screening may be more appropriate. Once this 
has been decided, assessing the importance of deter-
mining ethnicity may be the next decision. Irrespective 
of the screening method, consideration of ethnicity is 
still required to adequately inform patients or clients of 
their HbP risk. A validated tool to support health care 
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professionals to determine risk should therefore be 
considered.12,30 At the same time, support from national 
policy, whereby ethical and practical barriers are solved 
and financial issues clarified before such a programme 
is implemented, is crucial.
It may well be possible that for future generations, the 
necessity to determine ethnicity will become obsolete as 
ethnic admixture becomes more common in our multicul-
tural societies and complex deoxyribonucleic acid (DNA) 
testing for determining a wide range of genetic disorders 
can be offered during preconception screening.31
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